National Advertising Division Refers Problem Pregnancy Center to the MA Attorney General and Social Platforms for Review

New York, NY – May 16, 2024 – In a challenge brought by The Lawyering Project, a reproductive rights organization, BBB National Programs’ National Advertising Division has referred advertising claims made by Problem Pregnancy, a crisis pregnancy center, to the Massachusetts Attorney General and social media platforms after the company failed to provide a substantive response to the National Advertising Division’s inquiry.

The following represent the claims that served as the basis for this inquiry.

Express Claims

  • “Seeking abortion? Facing an unexpected pregnancy? We’re here to help.”
  • “If you’re pregnant and considering abortion, visit Problem Pregnancy. Our center… provides confidential abortion consultations to help you make an informed decision about your pregnancy. Make an appointment at Problem Pregnancy to talk about your personal situation, discuss the abortion methods that may be available to you and get answers to any questions you may have. All abortion consultations are free and confidential.”
  • “Learn more about the abortion pill, abortion procedures, and all your pregnancy options…Be empowered. Make an informed choice.”

 

Implied Claims

  • Problem Pregnancy provides complete and accurate reproductive health information, including about abortion.
  • Problem Pregnancy supports a woman’s right to choose any and all lawful options for addressing an unintended pregnancy.
  • Problem Pregnancy provides the same services as Planned Parenthood centers.

 

The Lawyering Project argued that the challenged claims convey the misleading message that Problem Pregnancy will provide complete information about all reproductive care options, including abortion, when in fact they do not.  

Despite repeated outreach attempts, Problem Pregnancy did not submit a substantive response to NAD’s inquiry or participate in the self-regulatory process. Per NAD/NARB Procedures, NAD has referred this matter to the Massachusetts Attorney General and social media platforms for review and possible enforcement action.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product

New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.

Read the Decision Summary
Decision

National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin

New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin. 

Read the Decision Summary
Decision

In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products

New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.” 

Read the Decision Summary
Decision

National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies

New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.

Read the Decision Summary